v3.26.1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Cash and cash equivalents    
Restricted cash $ 199 $ 169
Accumulated depreciation and amortization 12,441 12,039
Other assets, reserves for credit losses 121 86
Liabilities    
Long-term debt $ 58,750 $ 56,387
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares authorized (in shares) 20,000,000 20,000,000
Preferred shares, issued (in shares) 1,600 1,600
Preferred shares, outstanding (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 682,000,000 686,000,000
Common shares, outstanding (in shares) 682,000,000 686,000,000
Card Balances    
Cash and cash equivalents    
Financing receivables, gross $ 213,311 $ 213,863
Allowance for credit losses 6,065 6,089
Other Loans    
Cash and cash equivalents    
Financing receivables, gross 10,849 10,928
Allowance for credit losses 314 323
Variable Interest Entity, Primary Beneficiary    
Liabilities    
Long-term debt 13,278 13,022
Variable Interest Entity, Primary Beneficiary | Card Balances    
Cash and cash equivalents    
Financing receivables, gross 33,386 33,378
Variable Interest Entity, Primary Beneficiary | Cash    
Cash and cash equivalents    
Restricted cash 6 0
Variable Interest Entity, Primary Beneficiary | Interest-Bearing Deposits    
Cash and cash equivalents    
Restricted cash 19 0
Variable Interest Entity, Primary Beneficiary | Short-Term Investments    
Cash and cash equivalents    
Restricted cash $ 85 $ 84